Ramesh Mudududdla

6PUBLICATIONS
20CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 26, 2025
Utilizing the HiBiT System to Identify CARM1 Degraders for Targeted Cancer Therapy.

Megan Bacabac, Mingshan Hu, Fabao Liu

|Dec 08, 2025
Fluorinated pyrimidine 5-carboxamides as potential tools for MERTK targeted fluorine-18-PET-radioligand development.

Ramesh Mudududdla, Siu Wai Wong, Nghi Nguyen

|Jul 16, 2025
Development of Potent and Selective RIPK1 Degraders Targeting Its Nonenzymatic Function for Cancer Treatment.

Zhen Zhang, Chunrong Li, Nina J Hawkins

|Apr 10, 2025
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids.

Joel L Syphers, Josephine A Wright, Shen Liu

|May 27, 2023
Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV-In Vitro and In Vivo Evaluation.

Heba S Abd-Ellah, Ramesh Mudududdla, Glen P Carter

|Jan 21, 2023
Design, Development, and Optimisation of Smart Linker Chemistry for Targeted Colonic Delivery-In Vitro Evaluation.

Heba S Abd-Ellah, Ramesh Mudududdla, Glen P Carter

Pageof 1

Frequent Collaborators

2 joint publications

Jonathan B Baell

2 joint publications

Weiping Tang

1 joint publications

Heba S Abd-Ellah

1 joint publications

Joel L Syphers